These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33781665)

  • 1. N-myc-interactor mediates microbiome induced epithelial to mesenchymal transition and is associated with chronic lung allograft dysfunction.
    Banday MM; Kumar A; Vestal G; Sethi J; Patel KN; O'Neill EB; Finan J; Cheng F; Lin M; Davis NM; Goldberg H; Coppolino A; Mallidi HR; Dunning J; Visner G; Gaggar A; Seyfang A; Sharma NS
    J Heart Lung Transplant; 2021 Jun; 40(6):447-457. PubMed ID: 33781665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-33 mediates Pseudomonas induced airway fibrogenesis and is associated with CLAD.
    Banday MM; Rao SB; Shankar S; Khanday MA; Finan J; O'Neill E; Coppolino A; Seyfang A; Kumar A; Rinewalt DE; Goldberg HJ; Woolley A; Mallidi HR; Visner G; Gaggar A; Patel KN; Sharma NS
    J Heart Lung Transplant; 2023 Jan; 42(1):53-63. PubMed ID: 37014805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel role for tumor suppressor gene, liver kinase B1, in epithelial-mesenchymal transition leading to chronic lung allograft dysfunction.
    Rahman M; Ravichandran R; Bansal S; Sanborn K; Bowen S; Eschbacher J; Sureshbabu A; Fleming T; Bharat A; Walia R; Hachem R; Bremner RM; Smith MA; Mohanakumar T
    Am J Transplant; 2022 Mar; 22(3):843-852. PubMed ID: 34859569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Lung Microbiome Predicts Mortality and Response to Azithromycin in Lung Transplant Recipients with Chronic Rejection.
    Combs MP; Luth JE; Falkowski NR; Wheeler DS; Walker NM; Erb-Downward JR; Wakeam E; Sjoding MW; Dunlap DG; Admon AJ; Dickson RP; Lama VN
    Am J Respir Crit Care Med; 2024 Jun; 209(11):1360-1375. PubMed ID: 38271553
    [No Abstract]   [Full Text] [Related]  

  • 5. T Cells Promote Bronchial Epithelial Cell Secretion of Matrix Metalloproteinase-9 via a C-C Chemokine Receptor Type 2 Pathway: Implications for Chronic Lung Allograft Dysfunction.
    Pain M; Royer PJ; Loy J; Girardeau A; Tissot A; Lacoste P; Roux A; Reynaud-Gaubert M; Kessler R; Mussot S; Dromer C; Brugière O; Mornex JF; Guillemain R; Dahan M; Knoop C; Botturi K; Pison C; Danger R; Brouard S; Magnan A;
    Am J Transplant; 2017 Jun; 17(6):1502-1514. PubMed ID: 27982503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pulmonary microbiome: recent advances in understanding its role in chronic lung allograft dysfunction.
    Mitchell AB; Glanville AR
    Curr Opin Organ Transplant; 2022 Jun; 27(3):217-221. PubMed ID: 35649112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung microbiota predict chronic rejection in healthy lung transplant recipients: a prospective cohort study.
    Combs MP; Wheeler DS; Luth JE; Falkowski NR; Walker NM; Erb-Downward JR; Lama VN; Dickson RP
    Lancet Respir Med; 2021 Jun; 9(6):601-612. PubMed ID: 33460570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroproliferation in chronic lung allograft dysfunction: Association of mesenchymal cells in bronchoalveolar lavage with phenotypes and survival.
    Combs MP; Xia M; Wheeler DS; Belloli EA; Walker NM; Braeuer RR; Lyu DM; Murray S; Lama VN
    J Heart Lung Transplant; 2020 Aug; 39(8):815-823. PubMed ID: 32360292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: a bacterial 16S rRNA gene sequencing and host transcriptomic analysis.
    Ramsheh MY; Haldar K; Esteve-Codina A; Purser LF; Richardson M; Müller-Quernheim J; Greulich T; Nowinski A; Barta I; Stendardo M; Boschetto P; Korzybski D; Prasse A; Parr DG; Hohlfeld JM; Döme B; Welte T; Heath S; Gut I; Morrissey JA; Ziegler-Heitbrock L; Barer MR; Singh D; Brightling CE
    Lancet Microbe; 2021 Jul; 2(7):e300-e310. PubMed ID: 35544166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-Myc-interacting protein (NMI) negatively regulates epithelial-mesenchymal transition by inhibiting the acetylation of NF-κB/p65.
    Hou J; Wang T; Xie Q; Deng W; Yang JY; Zhang SQ; Cai JC
    Cancer Lett; 2016 Jun; 376(1):22-33. PubMed ID: 27012186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-21 in Lung Transplant Recipients With Chronic Lung Allograft Dysfunction.
    Miyahara N; Benazzo A; Oberndorfer F; Iwasaki A; Laszlo V; Döme B; Hoda MA; Jaksch P; Klepetko W; Hoetzenecker K
    Transpl Int; 2021; 35():10184. PubMed ID: 35185369
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction.
    Todd JL; Neely ML; Finlen Copeland CA; Frankel CW; Reynolds JM; Palmer SM
    J Heart Lung Transplant; 2019 Feb; 38(2):184-193. PubMed ID: 30466803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a post-transplant chronic lung allograft dysfunction classification system.
    Van Herck A; Verleden SE; Sacreas A; Heigl T; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck D; Verleden GM; Vos R
    J Heart Lung Transplant; 2019 Feb; 38(2):166-173. PubMed ID: 30391199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of azithromycin and allograft rejection on the post-lung transplant microbiota.
    Spence CD; Vanaudenaerde B; Einarsson GG; Mcdonough J; Lee AJ; Johnston E; Verleden GM; Elborn JS; Dupont LJ; Van Herck A; Gilpin DF; Vos R; Tunney MM; Verleden SE
    J Heart Lung Transplant; 2020 Feb; 39(2):176-183. PubMed ID: 31812487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short airway telomeres are associated with primary graft dysfunction and chronic lung allograft dysfunction.
    Greenland JR; Guo R; Lee S; Tran L; Kapse B; Kukreja J; Hays SR; Golden JA; Calabrese DR; Singer JP; Wolters PJ
    J Heart Lung Transplant; 2023 Dec; 42(12):1700-1709. PubMed ID: 37648073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of gram negative bacteria airway recolonization on the occurrence of chronic lung allograft dysfunction after lung transplantation in a population of cystic fibrosis patients.
    Orfanos S; Gomez C; Baron S; Akkisetty R; Dufeu N; Coltey B; Thomas PA; Rolain JM; Reynaud-Gaubert M
    BMC Microbiol; 2018 Aug; 18(1):88. PubMed ID: 30126365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung Allograft Microbiome Association with Gastroesophageal Reflux, Inflammation, and Allograft Dysfunction.
    Schneeberger PHH; Zhang CYK; Santilli J; Chen B; Xu W; Lee Y; Wijesinha Z; Reguera-Nuñez E; Yee N; Ahmed M; Boonstra K; Ramendra R; Frankel CW; Palmer SM; Todd JL; Martinu T; Coburn B
    Am J Respir Crit Care Med; 2022 Dec; 206(12):1495-1507. PubMed ID: 35876129
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of tumor necrosis factor-α in epithelial-to-mesenchymal transition in transplanted kidney cells in recipients with chronic allograft dysfunction.
    Zhao C; Xu Z; Wang Z; Suo C; Tao J; Han Z; Gu M; Tan R
    Gene; 2018 Feb; 642():483-490. PubMed ID: 29174387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Connective Tissue Growth Factor Is Overexpressed in Explant Lung Tissue and Broncho-Alveolar Lavage in Transplant-Related Pulmonary Fibrosis.
    Vanstapel A; Goldschmeding R; Broekhuizen R; Nguyen T; Sacreas A; Kaes J; Heigl T; Verleden SE; De Zutter A; Verleden G; Weynand B; Verbeken E; Ceulemans LJ; Van Raemdonck DE; Neyrinck AP; Schoemans HM; Vanaudenaerde BM; Vos R
    Front Immunol; 2021; 12():661761. PubMed ID: 34122421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.
    Sato M; Waddell TK; Wagnetz U; Roberts HC; Hwang DM; Haroon A; Wagnetz D; Chaparro C; Singer LG; Hutcheon MA; Keshavjee S
    J Heart Lung Transplant; 2011 Jul; 30(7):735-42. PubMed ID: 21419659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.